In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives

European Journal of Medicinal Chemistry

Volumn 45, Issue 5, 2010, Pages 2048-2054

  Achar, Kavitha C S ^a   Hosamani, Kallappa M ^a   Seetharamareddy, Harisha R ^a  

^a KARNATAK UNIVERSITY   (India)

Author keywords

2 (chloromethyl) 1H benzimidazole derivatives; Analgesic; Anti inflammatory; Benzimidazole derivatives

Indexed keywords

3 BROMO N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL]ANILINE; 4 BROMO N [(5 NITRO 1H BENZIMIDAZOL 2 YL)METHYL]ANILINE; ACETIC ACID; BENZIMIDAZOLE DERIVATIVE; CARRAGEENAN; N (1H BENZIMIDAZOL 2 YLMETHYL) 3 BROMOANILINE; N (1H BENZIMIDAZOL 2 YLMETHYL) 3 CHLOROANILINE; N (1H BENZIMIDAZOL 2 YLMETHYL) 4 METHOXYANILINE; N (1H BENZIMIDAZOL 2 YLMETHYL)ANILINE; N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL] 2 CHLOROANILINE; N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL] 3 CHLOROANILINE; N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL] 4 METHOXYANILINE; N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL] 4 METHYLANILINE; N [(5 BROMO 1H BENZIMIDAZOL 2 YL)METHYL]ANILINE; NIMESULIDE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PAW EDEMA; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZIMIDAZOLES; CARRAGEENAN; DRUG EVALUATION, PRECLINICAL; EDEMA; MICE; MOLECULAR STRUCTURE; PAIN; PAIN MEASUREMENT; RATS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77949490147     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2010.01.029     Document Type: Article

References (36)

1. Wilson L.M. In: Price S.A., and Wilson L.M. (Eds). Pathophysiology: Clinical Concepts of Disease Processes (2003), Mosby, St. Louis, Missouri 44-61
2. Collins T. In: Cotran R.S., Kumar V., and Collins T. (Eds). Robbins Pathologic Basis of Disease (2001), Harcourt India Pvt. Ltd., New Delhi 50-88
3. Garavito R.M. Nat. Struct. Biol. 3 (1996) 897-901
4. Vane J.R. Nature 231 (1971) 232-235
5. Vicini P., Incerti M., Amoretti L., Ballabeni V., Ognolini M., and Barocelli E. Il Farmaco 57 (2002) 363-367
6. Terioglu N., and Gursoy A. Eur. J. Med. Chem. 38 (2003) 781-786
7. Gadad A.K., Noolvi M.N., and Karpoormath R.K. Bioorg. Med. Chem. 12 (2004) 5651-5659
8. Andreani A., Granaiola M., Leoni A., Locatelli A., Morigi R., Rambaldi, Linaz G., Bergamini C., and Farruggia G. J. Med. Chem. 48 (2005) 3085-3089
9. Andreani A., Leoni A., Locatelli A., Morigi R., Rambaldi M., Recanatini M., and Garaliene V. Bioorg. Med. Chem. 8 (2000) 2359-2366
10. Sheehan D.J., Hitchcock C.A., and Sibley C.M. Clin. Microbiol. Rev. 12 (1999) 40-79
11. Lu J., Yang B., and Bai Y. Syn. Commun. 32 (2002) 3703-3709
12. Velyk J., Baliharova V., Fink-Gremmels J., Bull S., Lamka J., and Skalova L. Res. Veter. Sci. 76 (2004) 95-108
13. Liu J.F., Lee J., Dalton A.M., Bi G., Yu L., Baldino C.M., McElory E., and Brown M. Tet. Lett. 46 (2005) 1241-1244
14. Liu J.F., Wilson C.J., Ye P., Sprague K., Sargent K., Si Y., Beletski G., Yohannes D., and Ng S.C. Biorg. Med. Chem. Lett. 16 (2006) 686-690
15. Liu J.F., Kaselj M., Isome Y., Ye P., Sargent K., Sprague K., Cherrak D., Wilson C.J., Si Y., Yohannes D., and Ng S.C. J. Comb. Chem. 8 (2006) 7-10
16. Preston P.N. In the Chemistry of Heterocyclic Compounds, Benzimidazoles and Congeneric Tricyclic Compounds (1980), John Wiley & Son, New York p. 40
17. Evans B.E., Rittle K.E., Bock M.G., Dipardo R.M., Freidinger R.M., Whittel W.L., Lundell G.F., Veber D.F., Anderson P.S., Chang R.S.L., Lotti V.J., Cerino D.J., Chen T.V., Kling P.J., Kunkel K.A., Springer J.P., and Hirshfield J. J. Med. Chem. 31 (1988) 2235-2246
18. Ugur Y., Yarpuzlu A.A., Nazikoglu A., Asan E., Yildiz I., and Keles S. Turk. J. Med. Sci. 35 (2005) 5-12
19. Horton D.A., Bourne G.T., and Smythe M.L. Chem. Rev. 103 (2003) 893-930
20. Lin S.Y., Isome Y., Stewart E., Liu J.F., Yohannes D., and Libing Y. Tet. Lett. 47 (2006) 2883-2886
21. Labanauskas L.K., Brukstus A.B., Gaidelis P.G., Buchinskaite V.A., Udrenaite E.B., and Dauksas V.K. Pharm. Chem. J. 34 (2000) 353-355
22. Sondhi S.M., Rajvanshi S., Johar M., Bharti N., Azam A., and Singh A.K. Eur. J. Med. Chem. 37 (2002) 835-843
23. Hosamani K.M., Hiremath V.B., Keri R.S., Harisha R.S., and Halligudi S.B. Can. J. Chem. 86 (2008) 1030-1033
24. Hosamani K.M., Harisha R.S., Keri R.S., and Manohara S.H. J. Enzyme Inhib. Med. Chem. 24 (2009) 1095-1100
25. Harisha R.S., Hosamani K.M., and Keri R.S. Arch. Pharm. Chem. Life Sci. 342 (2009) 412-419
26. Shingalapur R.V., Hosamani K.M., and Keri R.S. Eur. J. Med. Chem. 44 (2009) 4244-4248
27. Madkour H.M.F., Mahmoud M.R., Sakr A.M., and Habushy M.M. Sci. Pharmazeut. 69 (2001) 33-52
28. Madkour H.M.F., Salem M.A.I., Soliman E.A., and Mahmoud N.F.H. J. Phosphorus Sulfur Silicon 170 (2001) 15-27
29. Madkour H.M.F., Salem M.A.I., Soliman E.A., and Mahmoud N.F.H. Heterocycles 53 (2000) 1129-1143
30. Raban M., Chang H., Craine L., and Hortelano E. J. Org. Chem. 50 (1985) 2205-2210
31. Madkor H.M.F., Farag A.A., Sh Ramses S., and Ibrahiem N.A.A. J. Phosphorus Sulfur Silicon 181 (2006) 255-265
32. Addison A.W., and Burke P.J. J. Heterocycl. Chem. 18 (1981) 803-805
33. Addison A.W., Rao T.N., and Wahlgren C.G. J. Heterocycl. Chem. 20 (1983) 1481-1484
34. Koster R., Anderson M., and De Beer E.J. Fed. Proc. 18 (1952) 412-421
35. Collier H.D.J., Dinnin L.C., Johnson C.A., and Schneider C. Br. J. Pharmacol. 32 (1968) 295-310
36. Winter C.A., Risley E.A., and Nuss G.W. Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547